1. Home
  2. NVRO

NVRO

Nevro Corp.

Logo Nevro Corp.

Health Care

Medical/Dental Instruments

Nasdaq

as 04-16-2024 4:00pm EST

$
-
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Nevro Corp is a medical device company. Its key product is the HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS system, an evidence-based neuromodulation system for the treatment of chronic pain. Senza generates electrical impulses to relieve pain. The system is implanted by physicians and controlled by patients. It consists of leads, a trial stimulator, an implantable pulse generator, surgical tools, a clinician laptop programmer, a patient remote control, and a mobile charger. The company generates the majority of its revenue in the United States.

Founded: 2006 Country:
United States
United States
Employees: N/A City: REDWOOD CITY
Market Cap: 480.8M IPO Year: 2014
Target Price: $19.58 AVG Volume (30 days): 451.4K
Analyst Decision: Hold Number of Analysts: 13
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -2.56 EPS Growth: N/A
52 Week Low/High: $12.34 - $39.68 Next Earning Date: 04-29-2024
Revenue: $425,174,000 Revenue Growth: 4.63%
Revenue Growth (this year): 5.77% Revenue Growth (next year): 6.00%

Share on Social Networks: